For the Inventor, By the Inventor

Enter inventor name

Millington, NJ, United States of America

Andrew L Zeitlin

USPTO Granted Patents = 26 (Patent Applications = 15)

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 16

Forward Citations = 1,258(Granted Patents)

Location History:

Green Brook, NJ (US) (1990 - 1992)
Somerville, NJ (US) (1994)
Millington, NJ (US) (1994 - 2008)
Somerset, NJ (US) (2015)
Basking Ridge, NJ (US) (2005 - 2016)

Company Filing History:

Celgene Corporation

Anthrogenesis Corporation

Celegene Corporation

4. 1 out of 836

University of Arkansas

5. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2016

Loading Chart...

Loading Chart...

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9464274 - Methods of generating natural killer cells (2016-10-11),

2. 9216200 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells (2015-12-22),

3. 9200253 - Method of producing erythrocytes (2015-12-01),

4. 8926964 - Methods of generating natural killer cells (2015-01-06),

5. 8455250 - Co-culture of placental stem cells and stem cells from a second source (2013-06-04),

6. 8263065 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells (2012-09-11),

7. 7700090 - Co-culture of placental stem cells and stem cells from a second source (2010-04-20),

8. 7479499 - Methods of using thalidomide in combination with irinotecan (2009-01-20),

9. 7435726 - Compositions and methods for the treatment of cancer (2008-10-14),

10. 7431944 - Delivery of multiple doses of medications (2008-10-07),

11. 7115631 - Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate (2006-10-03),

12. 6914067 - Compositions and methods for the treatment of colorectal cancer (2005-07-05),

13. 6635284 - Delivery of multiple doses of medications (2003-10-21),

14. 6602887 - Chronic, bolus administration of D-threo methylphenidate (2003-08-05),

15. 6528530 - Phenidate drug formulations having diminished abuse potential (2003-03-04),

Title: The Inventor Andrew L Zeitlin: Pioneering Innovations in Millington, NJ

Introduction: Andrew L Zeitlin is a distinguished inventor based in Millington, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Andrew L Zeitlin holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and ingenuity in inventing solutions for modern challenges.

Career Highlights: With a career spanning over two decades, Andrew L Zeitlin has consistently pushed the boundaries of innovation, with his inventions garnering recognition for their practicality and impact on society.

Collaborations: Throughout his career, Andrew L Zeitlin has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Andrew L Zeitlin's passion for innovation and his dedication to creating solutions that improve lives make him a standout figure in the world of inventors, with his work continuing to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…